Combining CGRP mAbs and gepants: what do we know?20 October 2021View Newsletter »
CGRP Forum highlights from the XXV World Congress of Neurology 20218 October 2021View Newsletter »
CGRP Forum highlights from the International Headache Congress 202114 September 2021View Newsletter »
In case you missed it … recent news from CGRP Forum3 September 2021View Newsletter »
CGRP Forum news from the 7th EAN congress 202125 June 2021View Newsletter »
CGRP Forum news from the 63rd annual AHS meeting 20218 June 2021View Newsletter »
CGRP Forum news from the virtual AAN meeting 202126 April 2021View Newsletter »
Latest news from CGRP Forum: Clinical trials update20 April 2021View Newsletter »
Recent news from the CGRP Forum26 February 2020View Newsletter »
Recent news from the CGRP Forum24 January 2020View Newsletter »
Recent news from the CGRP Forum13 January 2020View Newsletter »
Latest news from CGRP Forum: World Congress of Neurology 20196 November 2019View Newsletter »
Latest news from CGRP Forum: In case you missed it18 October 2019View Newsletter »
Is anti-CGRP therapy approved for your patients?26 September 2019View Newsletter »
Latest news from CGRP Forum: IHC 201916 September 2019View Newsletter »
Latest news from CGRP Forum: AHS Coverage14 July 2019View Newsletter »
Coverage from the 5th Congress of the European Academy of Neurology2 July 2019View Newsletter »
Live coverage from the the 13th European Headache Congress31 May 2019View Newsletter »
Latest news from CGRP Forum: EHF Coverage30 May 2019View Newsletter »
Latest news from CGRP Forum: AAN Coverage9 May 2019View Newsletter »
Latest News from CGRP Forum: Aimovig (erenumab) available for chronic migraine prophylaxis on NHS in Scotland11 April 2019View Newsletter »
In case you missed it …27 March 2019View Newsletter »
Latest News from CGRP Forum: CGRP Therapy Guidelines Published8 March 2019View Newsletter »
Latest news from CGRP Forum21 February 2019View Newsletter »
In case you missed it11 December 2018View Newsletter »
Recent news from the CGRP Forum28 November 2018View Newsletter »
Recent News from the CGRP Forum9 November 2018View Newsletter »
Anti-CGRP therapy: where does it fit in our clinics?17 October 2018View Newsletter »
News from the 12th European Headache Federation Congress3 October 2018View Newsletter »
Emgality (galcanezumab) approved for migraine prevention in USA28 September 2018View Newsletter »
Ajovy (fremanezumab) wins US approval in migraine prevention19 September 2018View Newsletter »
News from 17th Biennial Migraine Trust International Symposium13 September 2018View Newsletter »
Recent News from the CGRP Forum4 September 2018View Newsletter »
Latest news from the CGRP Forum29 August 2018View Newsletter »
Latest news from the CGRP Forum2 August 2018View Newsletter »
News from American Headache Society’s 60th Annual Scientific Meeting5 July 2018View Newsletter »
News from EAN 201819 June 2018View Newsletter »
News from CGRP Fourm14 June 2018View Newsletter »
Aimovig (erenumab) approved for migraine prevention in US adults19 May 2018View Newsletter »
News from the CGRP Forum18 May 2018View Newsletter »
News from the CGRP Forum2 May 2018View Newsletter »
AAN 2018: Latest CGRP inhibitor data…27 April 2018View Newsletter »
News from the CGRP Forum26 April 2018View Newsletter »
News from the CGRP Forum16 April 2018View Newsletter »
Latest news from the CGRP Forum1 February 2018View Newsletter »
EHF 2017: More studies reveal benefits of CGRP inhibitors in migraine prevention8 December 2017View Newsletter »
Just published in the New England Journal of Medicine30 November 2017View Newsletter »
IHC 2017 Scientific Sessions News2 October 2017View Newsletter »